Literature DB >> 27306200

[Molecular imaging of head and neck cancers : Perspectives of PET/MRI].

P Stumpp1, S Purz2, O Sabri2, T Kahn3.   

Abstract

BACKGROUND: The (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG-PET/CT) procedure is a cornerstone in the diagnostics of head and neck cancers. Several years ago PET-magnetic resonance imaging (PET/MRI) also became available as an alternative hybrid multimodal imaging method.
OBJECTIVE: Does PET/MRI have advantages over PET/CT in the diagnostics of head and neck cancers?
MATERIAL AND METHODS: The diagnostic accuracy of the standard imaging methods CT, MRI and PET/CT is depicted according to currently available meta-analyses and studies concerning the use of PET/MRI for these indications are summarized.
RESULTS: In all studies published up to now PET/MRI did not show superiority regarding the diagnostic accuracy in head and neck cancers; however, there is some evidence that in the future PET/MRI can contribute to tumor characterization and possibly be used to predict tumor response to therapy with the use of multiparametric imaging.
CONCLUSION: Currently, (18)F-FDG-PET/CT is not outperformed by PET/MRI in the diagnostics of head and neck cancers. The additive value of PET/MRI due to the use of multiparametric imaging needs to be investigated in future research.

Entities:  

Keywords:  Meta-analyses; Multimodal imaging; Multiparametric diagnostics; Therapy response; Tumor characterization

Mesh:

Substances:

Year:  2016        PMID: 27306200     DOI: 10.1007/s00117-016-0125-7

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  33 in total

Review 1.  Tumor response assessments with diffusion and perfusion MRI.

Authors:  Sonia P Li; Anwar R Padhani
Journal:  J Magn Reson Imaging       Date:  2012-04       Impact factor: 4.813

2.  Qualitative and quantitative performance of ¹⁸F-FDG-PET/MRI versus ¹⁸F-FDG-PET/CT in patients with head and neck cancer.

Authors:  S Partovi; A Kohan; J L Vercher-Conejero; C Rubbert; S Margevicius; M D Schluchter; C Gaeta; P Faulhaber; M R Robbin
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

3.  Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study.

Authors:  Max Lonneux; Marc Hamoir; Hervé Reychler; Philippe Maingon; Christian Duvillard; Gilles Calais; Boumédiène Bridji; Laurence Digue; Michel Toubeau; Vincent Grégoire
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

4.  Contrast-enhanced PET/MR imaging versus contrast-enhanced PET/CT in head and neck cancer: how much MR information is needed?

Authors:  Felix P Kuhn; Martin Hüllner; Caecilia E Mader; Nikos Kastrinidis; Gerhard F Huber; Gustav K von Schulthess; Spyros Kollias; Patrick Veit-Haibach
Journal:  J Nucl Med       Date:  2014-02-03       Impact factor: 10.057

Review 5.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

6.  Combined PET/MR: The Real Work Has Just Started. Summary Report of the Third International Workshop on PET/MR Imaging; February 17-21, 2014, Tübingen, Germany.

Authors:  D L Bailey; G Antoch; P Bartenstein; H Barthel; A J Beer; S Bisdas; D A Bluemke; R Boellaard; C D Claussen; C Franzius; M Hacker; H Hricak; C la Fougère; B Gückel; S G Nekolla; B J Pichler; S Purz; H H Quick; O Sabri; B Sattler; J Schäfer; H Schmidt; J van den Hoff; S Voss; W Weber; H F Wehrl; T Beyer
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

7.  In Vivo Correlation of Glucose Metabolism, Cell Density and Microcirculatory Parameters in Patients with Head and Neck Cancer: Initial Results Using Simultaneous PET/MRI.

Authors:  Matthias Gawlitza; Sandra Purz; Klaus Kubiessa; Andreas Boehm; Henryk Barthel; Regine Kluge; Thomas Kahn; Osama Sabri; Patrick Stumpp
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

Review 8.  Computed tomography versus magnetic resonance imaging for diagnosing cervical lymph node metastasis of head and neck cancer: a systematic review and meta-analysis.

Authors:  J Sun; B Li; C J Li; Y Li; F Su; Q H Gao; F L Wu; T Yu; L Wu; L J Li
Journal:  Onco Targets Ther       Date:  2015-06-08       Impact factor: 4.147

9.  Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study.

Authors:  Soo Jin Lee; Hyo Jung Seo; Gi Jeong Cheon; Ji Hoon Kim; E Edmund Kim; Keon Wook Kang; Jin Chul Paeng; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-12-06

10.  Detection and quantification of focal uptake in head and neck tumours: (18)F-FDG PET/MR versus PET/CT.

Authors:  Arthur Varoquaux; Olivier Rager; Antoine Poncet; Bénédicte M A Delattre; Osman Ratib; Christoph D Becker; Pavel Dulguerov; Nicolas Dulguerov; Habib Zaidi; Minerva Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-10-10       Impact factor: 9.236

View more
  1 in total

1.  Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides.

Authors:  Dina V Hingorani; Aaron J Lemieux; Joseph R Acevedo; Heather L Glasgow; Suraj Kedarisetty; Michael A Whitney; Alfredo A Molinolo; Roger Y Tsien; Quyen T Nguyen
Journal:  Oral Oncol       Date:  2017-06-27       Impact factor: 5.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.